Cationized hyperimmune immunoglobulins: Pharmacokinetics, toxicity evaluation and treatment of human immunodeficiency virus-infected human-peripheral blood lymphocytes-severe combined immune deficiency mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 246-252

  Pardridge, William M ^a   Kang, Young Sook ^a,b   Diagne, Amadou ^a   Zack, Jerome A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERIMMUNE GLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; COMBINED IMMUNODEFICIENCY; DOSE RESPONSE; DRUG EFFICACY; DRUG UPTAKE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TOXICITY TESTING;

ANIMALS; ANTIVIRAL AGENTS; CATIONS; CELLS, CULTURED; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; VIRUS REPLICATION;

EID: 0029873942     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ALDROVANDI, G. M., FEUER, G., GAO, L., JAMIESON, B., KRISTEVA, M., CHEN, I. S. Y. ANB ZACK, J. A.: The SCID-hu mouse as a model for HIV-1 infection. Nature (Lond.) 363: 732-736, 1993.
2. BARONE, A. D., SILVA, J. J., HO, D. D., GALLO, R. C., WONG-STAAL, F. F. AND CHANG, N. T.. Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome. J. Immunol. 137: 669-673, 1986.
3. BELL, D. R., WATSON, P. D. AND RENKIN, E. M.: Exclusion of plasma proteins in interstitium of tissues from the dog hind paw. Am. J Physiol. 239: H532-H538, 1980.
4. BICKEL, U., LEE, V. M. Y., TROJANOWSKI, J. Q. AND PARDRIDGE, W. M.: Development and in vitro characterization of a cationized monoclonal antibody against βA4 protein: A potential probe for Alzheimer's disease. Bioconj. Chem. 5: 119-125, 1994.
5. CHEN, S.-Y., KHOURI, Y., BAGLEY, J. AND MARASCO, W. A.: Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Proc. Natl. Acad. Sci. U.S.A. 91: 5932-5936, 1994.
6. COFFIN, J. M.: HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science (Wash. DC) 267: 483-489, 1995.
7. CUMMINS, L. M , WEINHOLD, K. J., MATTHEWS, T. J., LANGLOIS, A. J., PERNO, C. F., CONDIE, R. M. AND ALLAIN, J.-P.: Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors. Blood 77: 1111-1117, 1991.
8. 131 plasma proteins in the rat. Am J. Physiol. 197: 423-431, 1959.
9. FAUCI, A. S.: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy Science (Wash. DC) 262: 1011-1018, 1993.
10. FOSTER, H. L., SMALL, J. D. AND FOX, J. G.: The mouse in biomedical research. In Volume III. Normative Biology, Immunology, and Husbandry, pp. 108-109, Academic Press, New York, 1983.
11. GIBALDI, M. AND PERRIER, D.: Pharmacokinetics, Marcel Dekker, Inc. New York, 1982.
12. HINKULA, J., BRATT, G., GILLJAM, G., NORDLUND, S., BROLIDEN, P. A., HOLMBERG, V., OLAUSSON-HANSSON, E., ALBERT, J., SANDSTRÖM, E. AND WAHREN, B.: Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies. J. Acquired Immune Defic Syndr. 7: 940-951, 1994.
13. KANG, Y.-S. AND PARDRIDGE, W M.: Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin. Pharm. Res. 11: 1257-1264, 1994.
14. MARASCO, W. A., HASELTINE, W. A. AND CHEN, S.: Design, intracellular expression and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc. Natl. Acad. Sci. U.S.A. 90: 7889-7893, 1993
15. MOSIER, D. E., GULIZIA, R J., BAIRD, S. M., WILSON, D. B., SPECTOR, D. H AND SPECTOR, S. A.: Human immunodeficiency virus infection of human-PBL-SCID mice. Science (Wash. DC) 251: 791-794, 1991.
16. + T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science (Wash. DC) 260: 689-692, 1993.
17. MUCKERHEIDE, A., APPLE, R. J., PESCE, A. J. AND MICHAEL, J. G.: Cationization of protein antigens. J. Immunol. 138: 833-837, 1987.
18. PANG, S., VINTERS, H. V., AKASHI, T., O'BRIEN, W. A. AND CHEN, I. S. Y.: HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J. Acquired Immune Defic. Syndr. 4: 1082-1092, 1991.
19. PARDRIBGE, W. M., BUCIAK, J., YANG, J. AND DIAGNE, A.: Treatment of human immunodeficiency virus-infected lymphocytes with cationized human immunoglobulins. J. Infect. Dis. 170: 563-569, 1994a
20. PARDRIDGE, W. M., BICKEL, U., BUCIAK, J., YANG, J. AND DIAGNE, A.: Enhanced endocytosis and anti-HIV-1 activity of anti-rev antibodies following cationization. J. Infect. Dis. 169: 55-61, 1994b.
21. PARDRIDGE, W. M., BICKEL, U., BUCIAK, J., YANG, J., DIAGNE, A. AND AEPINTS, C.: Cationization of a monoclonal antibody to the human immunodeficiency virus rev protein enhances cellular uptake but does not impair antigen binding of the antibody Immunol. Lett 42: 191-195, 1994c.
22. PARDRIDGE, W. M., KANG, Y.-S., YANG, J. AND BUCIAK, J. L.: Enhanced cellular uptake and in vivo biodistribution of a monoclonal antibody following cationization. J. Pharm. Sci., 84: 943-948, 1995.
23. PARDRIDGE, W. M., TRIGUERO, D., BUCIAK, J. L. AND YANG, J : Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector. J. Pharmacol. Exp. Ther. 255: 893-899, 1990.
24. PRINCE, A. M., REESINK, H., PASCUAL, D., HOROWITZ, B., HEWLETT, I., MURTHY, K. K., COBB, K. E. AND EICHBERG, J. W.: Prevention of HIV infection by passive immunization with HIV immunoglobulin AIDS Res Human Retroviruses 7: 971-973, 1991.
25. ROSS, C., SVENSON, M , HANSEN, M. B., VEJLSGAARD, G. L. AND BENDTZEN, K. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG. J. Clin. Invest. 95: 1974-1978, 1995.
26. SAFRIT, J. T., FUNG, M S. C., ANDREWS, C. A., BRAUN, D. G., SUN, W. N. C., CHANG, T. W. AND KOUP, R. A., hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120. AIDS 7:15-21, 1993.
27. SVENSON, M., HANSEN, M. B. AND BENDTZEN, K.: Binding of cytokines to pharmaceutically prepared human immunoglobulin. J. Clin. Invest. 92: 2533-2539, 1993.
28. TRIGUERO, D., BUCIAK, J. B., YANG, J. AND PARDRIDGE, W. M.: Blood-brain barrier transport of cationized immunoglobulin G. Enhanced delivery compared to native protein. Proc. Natl. Acad. Sci. U.S.A. 86: 4761-4765, 1989.
29. TRIGUERO, D., BUCIAK, J. L. AND PARDRIDGE, W. M.. Cationization of immunoglobulin G results in enhanced organ uptake of the protein following intravenous administration in rats and primate. J. Pharmacol Exp. Ther. 258: 186-192, 1991.
30. WERGE, T. M., BIOCCA, S. AND CATTANEO, A.: Intracellular immunization. Cloning and intracellular expression of a monoclonal antibody to the p21ras protein. FEBS Lett. 274: 193-198, 1990.